Diebold Nixdorf (DBD) Misses Q4 EPS by 8c, Revenue Beats, Offers Guidance
Tweet
Share
E-mail
Get Alerts DBD Hot Sheet
Price: $67.08 -2.32%
Financial Fact:
Income from continuing operations, net of tax: -21.6M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Income from continuing operations, net of tax: -21.6M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Diebold Nixdorf (NYSE: DBD) reported Q4 EPS of ($0.08), $0.08 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.22 billion.
GUIDANCE:
Diebold Nixdorf sees FY2019 revenue of $4.4-4.5 billion, versus the consensus of $4.54 billion.
For earnings history and earnings-related data on Diebold Nixdorf (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- BMO Capital Starts American Eagle Outfitters (AEO) at Market Perform
- UBS upgrades Lockheed Martin to Buy, sees 26% upside on missile growth
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
